310 related articles for article (PubMed ID: 33845061)
1. Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates.
Wang W; Lempp FA; Schlund F; Walter L; Decker CC; Zhang Z; Ni Y; Urban S
J Hepatol; 2021 Aug; 75(2):311-323. PubMed ID: 33845061
[TBL] [Abstract][Full Text] [Related]
2. Support of the infectivity of hepatitis delta virus particles by the envelope proteins of different genotypes of hepatitis B virus.
Freitas N; Abe K; Cunha C; Menne S; Gudima SO
J Virol; 2014 Jun; 88(11):6255-67. PubMed ID: 24648462
[TBL] [Abstract][Full Text] [Related]
3. Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles.
Freitas N; Cunha C; Menne S; Gudima SO
J Virol; 2014 May; 88(10):5742-54. PubMed ID: 24623409
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin.
Gomes-Gouvêa MS; Pereira Soares Mdo C; Guedes de Carvalho Mello IM; Brito EM; Pereira Moia Lde J; Bensabath G; Nunes HM; Carrilho FJ; Pinho JR
Acta Trop; 2008 Jun; 106(3):149-55. PubMed ID: 18420172
[TBL] [Abstract][Full Text] [Related]
5. [Delta hepatitis: Epidemiology, diagnostic, natural history and treatment].
Loureiro D; Castelnau C; Bed CM; Asselah T
Rev Med Interne; 2022 Mar; 43(3):160-169. PubMed ID: 34799189
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
Blanchet M; Sureau C
J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
[TBL] [Abstract][Full Text] [Related]
7. Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies.
Julithe R; Abou-Jaoudé G; Sureau C
J Virol; 2014 Aug; 88(16):9049-59. PubMed ID: 24899172
[TBL] [Abstract][Full Text] [Related]
8. Interplay between Hepatitis D Virus and the Interferon Response.
Zhang Z; Urban S
Viruses; 2020 Nov; 12(11):. PubMed ID: 33233762
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus.
Shih HH; Jeng KS; Syu WJ; Huang YH; Su CW; Peng WL; Sheen IJ; Wu JC
J Virol; 2008 Mar; 82(5):2250-64. PubMed ID: 18094179
[TBL] [Abstract][Full Text] [Related]
10. Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion.
Sureau C; Guerra B; Lanford RE
J Virol; 1993 Jan; 67(1):366-72. PubMed ID: 8416375
[TBL] [Abstract][Full Text] [Related]
11. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
[TBL] [Abstract][Full Text] [Related]
12. Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV.
Mateo R; Xu S; Shornikov A; Yazdi T; Liu Y; May L; Han B; Han D; Martin R; Manhas S; Richards C; Marceau C; Aeschbacher T; Chang S; Manuilov D; Hollnberger J; Urban S; Asselah T; Abdurakhmanov D; Lampertico P; Maiorova E; Mo H
JHEP Rep; 2023 Nov; 5(11):100893. PubMed ID: 37929228
[TBL] [Abstract][Full Text] [Related]
13. New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies.
Zhang Z; Urban S
J Hepatol; 2021 Mar; 74(3):686-699. PubMed ID: 33276031
[TBL] [Abstract][Full Text] [Related]
14. [Bulevirtide as the first specific agent against hepatitis D virus infections-mechanism and clinical effect].
Nkongolo S; Hollnberger J; Urban S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Feb; 65(2):254-263. PubMed ID: 35028672
[TBL] [Abstract][Full Text] [Related]
15. The role of the HBV envelope proteins in the HDV replication cycle.
Sureau C
Curr Top Microbiol Immunol; 2006; 307():113-31. PubMed ID: 16903223
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.
Khabir M; Aliche AZ; Sureau C; Blanchet M; Labonté P
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748400
[TBL] [Abstract][Full Text] [Related]
17. Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies.
Allweiss L; Volmari A; Suri V; Wallin JJ; Flaherty JF; Manuilov D; Downie B; Lütgehetmann M; Bockmann JH; Urban S; Wedemeyer H; Dandri M
J Hepatol; 2024 Jun; 80(6):882-891. PubMed ID: 38340811
[TBL] [Abstract][Full Text] [Related]
18. Bulevirtide for HBV and HDV infections.
Yardeni D; Koh C
Drugs Today (Barc); 2021 Jul; 57(7):433-448. PubMed ID: 34268531
[TBL] [Abstract][Full Text] [Related]
19. A tryptophan-rich motif in the carboxyl terminus of the small envelope protein of hepatitis B virus is central to the assembly of hepatitis delta virus particles.
Komla-Soukha I; Sureau C
J Virol; 2006 May; 80(10):4648-55. PubMed ID: 16641257
[TBL] [Abstract][Full Text] [Related]
20. Future treatments for hepatitis delta virus infection.
Asselah T; Loureiro D; Tout I; Castelnau C; Boyer N; Marcellin P; Mansouri A
Liver Int; 2020 Feb; 40 Suppl 1():54-60. PubMed ID: 32077603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
